Writing a Materials and Methods Section: The Reagent Detail That Lets Someone Repeat the Work

A materials and methods section is written for one reader: a competent scientist in another laboratory who wants to repeat the work. Every decision about what to include follows from that. The ICMJE recommendations frame it as detail sufficient for others with access to the data to reproduce the results ^[1]; ARRIVE 2.0 asks, for animal studies, that the procedures for each experimental group, including controls, be described in enough detail to allow others to replicate them ^[2]. The commonest failure is not error but under-specification — a section that is accurate throughout and still cannot be followed.

This article is about the section as a whole: its structure, its level of detail, and the preparation and storage facts most often left out. The single statement describing where one purchased compound came from, and the four facts that statement must carry, is the subject of this cluster's pillar; here it is one line in a longer document.

What the section is for

The methods section is the part of a paper that makes the rest of it checkable. Results can be argued with; the methods decide whether anyone can find out if the argument was right. Nature Portfolio states the practical consequence directly: submissions should contain complete descriptions of the materials and reagents used, materials and associated protocols are to be made available to readers, and any restriction on that availability must be stated in the paper ^[4].

A useful test while drafting: could a graduate student in a well-equipped laboratory elsewhere, holding only this section and the supplementary files, set up the same experiment? Wherever the honest answer is "only after asking me", something is missing.

Level of detail, and the under-specification failure

Under-specification rarely looks like a gap to its author, because the author knows the missing fact. "Cells were treated with the peptide" reads as complete to the person who made the solution; to anyone else it hides the solvent, the concentration, the age of the solution and how it was stored. The ARRIVE explanation-and-elaboration document gives the reasoning: describing what was done, how, when, where and why for each group is what allows others to replicate the procedure and judge its reliability ^[3].

The cost is not hypothetical. Freedman and colleagues grouped the sources of irreproducible preclinical research into four categories — study design, biological reagents and reference materials, laboratory protocols, and data analysis and reporting — and estimated the cumulative prevalence of irreproducible preclinical work at more than 50% ^[7]. Two of those four categories live in the methods section, and the price of an underspecified protocol is paid by the next laboratory to attempt it.

Reagents, equipment, procedure, analysis

Most methods sections divide cleanly into four parts, and journals with structured formats make the division explicit. The Key Resources Table used by Cell Press journals lists reagents, cell lines, organisms and software with a source and an identifier — catalogue numbers, RRIDs, accession or CAS numbers — so that the prose can concentrate on procedure ^[5].

1. Reagents and materials: source, catalogue number, lot, purity with method, and form for each critical item; common chemicals and standard media need less ^[5].
2. Equipment: make and model wherever the instrument's characteristics affect the measurement — a plate reader's detection mode, a column's dimensions and chemistry.
3. Procedure: the sequence of operations with quantities, times and temperatures, in the order they were performed, for every group including controls ^[2].
4. Analysis: the software and its version, the statistical tests, the unit of analysis, and how exclusions were decided ^[6].

The MDAR framework makes a useful cross-check because it cuts the same material a different way. For each item it asks whether it is accessible, whether it is identified with enough information for unique designation and provenance, and whether it is characterised to the minimum needed for interpretation and replication ^[6]. An item that fails any of the three needs another clause.

What reviewers most often ask to be added

Reviewers' requests cluster around a small set of omissions. None is exotic; each is a fact the authors knew and did not write down.

• Which batch: a lot number for any reagent whose quality could plausibly vary.
• How purity and identity were established, and by whom — not just a percentage.
• The concentration basis: whether a stated molarity was corrected for salt and water content.
• Vehicle and controls: what the control arm received, prepared the same way ^[2].
• Solution age and storage: how long a prepared solution was kept, and under what conditions, before use.
• Deviations from a cited method: "as previously described", followed by what was changed.

A companion article in this cluster works through the provenance questions in detail, including how to answer them when the material came from a commercial research supplier.

Preparation and storage: the details most often left out

The step between a container arriving and its contents entering an experiment is where laboratories differ most and report least. It is also where a reagent can change. The minimum description of a prepared solution covers the solvent and its grade; the concentration and whether it is on a gross or corrected basis; whether and how it was filtered; the container material; the storage temperature; whether it was aliquoted; how many freeze–thaw cycles were allowed; and the age of the solution at the point of use. How a stock solution and its dilution series are prepared and recorded is a procedure in its own right, and the methods section should let a reader reconstruct it.

Most of these facts are already written down somewhere in the laboratory — provided the work was run to a written instruction. A methods section drafted from a standard operating procedure written for the bench comes out more complete, because the procedure already lists the steps an author would otherwise reconstruct from memory. Where a step departed from the procedure, that departure is exactly what belongs in the paper ^[1].

Dates, lot numbers and deviations come from the other contemporaneous record. A notebook entry that is dated, attributable and written as the work was done is the source a methods section should be written from — not recollection a year and a half later, when a reviewer asks which lot went into which experiment.

A checklist before submission

1. Every critical reagent has a source, catalogue number and lot ^[5].
2. Every purity figure has a method and an attributed source.
3. Every prepared solution has a solvent, grade, concentration basis, storage condition and maximum age at use.
4. Every instrument whose properties affect a measurement is named with its model.
5. Every cited method is followed by its deviations, or a statement that there were none.
6. Controls are described in the same detail as the other arms ^[2].
7. Software is named with its version; statistical tests are named with what was compared ^[6].
8. Supplementary files hold the certificates, protocols or records the text relies on ^[4].
9. A colleague outside the project has read the section and listed what they would need to ask.

The last item catches the most. Authors cannot see their own omissions; a reader without the context finds them in minutes, which is a good deal cheaper than a reviewer finding them a month into the process.